Skip to main content
Year archive

ALGORAE PHARMACEUTICALS LIMITED — 2021 filings

All 61 regulatory filings released by ALGORAE PHARMACEUTICALS LIMITED (1AI) in 2021, sourced directly from the official regulator.

61 Filings
2021 Period
2021 filings (61)
Filing Released Lang
Results of Rights Issue 2 pages 111.9KB
Capital/Financing Update
2021-12-28 English
Application for quotation of securities - LCT 6 pages 27.6KB
Share Issue/Capital Change
2021-12-28 English
Update - Application for quotation of securities - LCT 6 pages 27.0KB
Capital/Financing Update
2021-12-28 English
Update - Appendix 2A- Issue of shares and Options 16 pages 303.8KB
Regulatory Filings
2021-12-20 English
Notification of cessation of securities - LCT 4 pages 24.1KB
Share Issue/Capital Change
2021-12-14 English
Application for quotation of securities - LCT 7 pages 30.2KB
Capital/Financing Update
2021-12-13 English
LCT to Issue Compensation Options 2 pages 147.2KB
Capital/Financing Update
2021-12-12 English
Proposed issue of securities - LCT 6 pages 30.1KB
Capital/Financing Update
2021-12-12 English
Cleansing Notice 3 pages 167.8KB
Capital/Financing Update
2021-12-12 English
LCT Appoints COO to Establish NTCELL Trial 2 pages 146.9KB
Board/Management Information
2021-12-12 English
Extension of Rights Issue 2 pages 145.4KB
Capital/Financing Update
2021-12-08 English
Update - Proposed issue of securities - LCT 8 pages 36.6KB
Capital/Financing Update
2021-12-08 English
Appendix 2A- Issue of shares and Options 16 pages 303.6KB
Capital/Financing Update
2021-11-30 English
Chairman's Address to the General Meeting 2 pages 406.8KB
AGM Information
2021-11-28 English
Chairman Presentation 13 pages 1.7MB
AGM Information
2021-11-28 English
Results of General Meeting 3 pages 585.8KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-28 English
Cleansing Notice 3 pages 446.2KB
Capital/Financing Update
2021-11-28 English
Proposed issue of securities - LCT 9 pages 39.9KB
Capital/Financing Update
2021-11-28 English
Non-Renounceable Rights Issue Opens 9 pages 704.8KB
Capital/Financing Update
2021-11-22 English
LCT- Rights Issue 3 pages 448.6KB
Capital/Financing Update
2021-11-14 English
Prospectus- Rights Issue 32 pages 960.0KB
Capital/Financing Update
2021-11-14 English
Proposed issue of securities - LCT 8 pages 36.9KB
Capital/Financing Update
2021-11-14 English
Update - Proposed issue of securities - LCT 8 pages 36.6KB
Capital/Financing Update
2021-11-14 English
Chairman's Address to the 2021 Annual General Meeting 4 pages 160.9KB
AGM Information
2021-11-10 English
CEO's presentation to AGM 19 pages 875.2KB
AGM Information
2021-11-10 English
Results of Annual General Meeting 3 pages 586.2KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-10 English
LCT Receives New Zealand R&D Tax Credit 2 pages 455.8KB
Regulatory Filings
2021-11-08 English
LCT Advises Price Change for Rights Issue 2 pages 445.9KB
Capital/Financing Update
2021-11-07 English
Quarterly Activity Report and Appendix 4C 8 pages 1.1MB
Interim / Quarterly Report
2021-10-28 English
Notice of General Meeting/ Proxy Form 23 pages 1.5MB
AGM Information
2021-10-27 English
LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial 3 pages 545.2KB
Capital/Financing Update
2021-10-25 English
Application for quotation of securities - LCT 6 pages 27.4KB
Share Issue/Capital Change
2021-10-19 English
Secures Funds for 3rd Trial of NTCELL in Parkinson Disease 5 pages 559.3KB
Capital/Financing Update
2021-10-18 English
Proposed issue of securities - LCT 5 pages 28.1KB
Capital/Financing Update
2021-10-18 English
Cleansing Notice 2 pages 448.3KB
Capital/Financing Update
2021-10-18 English
Pause in Trading 1 page 112.1KB
Regulatory Filings
2021-10-14 English
Trading Halt 4 pages 535.2KB
Regulatory Filings
2021-10-14 English
2021 Annual General Meeting 20 pages 1.5MB
AGM Information
2021-10-07 English
Annual Report to shareholders 44 pages 8.6MB
Annual Report
2021-10-07 English
Appendix 4G and Corporate Governance Statement 26 pages 765.7KB
Regulatory Filings
2021-10-07 English
Notification of cessation of securities - LCT 4 pages 24.2KB
Share Issue/Capital Change
2021-09-02 English
Preliminary Final Report and 2021 Financial Statements 47 pages 989.2KB
Annual Report
2021-08-30 English
Business Update 2 pages 446.2KB
Regulatory Filings
2021-08-15 English
Quarterly Activity Report and Appendix 4C 7 pages 1.1MB
Interim / Quarterly Report
2021-07-29 English
Appendix 3Z - K Taylor 2 pages 317.5KB
Director's Dealing
2021-07-18 English
LCT Interim CEO Appointed 2 pages 437.0KB
Board/Management Information
2021-07-15 English
Notification of cessation of securities - LCT 4 pages 24.2KB
Share Issue/Capital Change
2021-07-01 English
Change of Director's Interest Notice - K Taylor 2 pages 665.0KB
Director's Dealing
2021-07-01 English
Response to ASX Price Query 4 pages 842.4KB
Regulatory Filings
2021-07-01 English
Business Update 2 pages 436.5KB
Regulatory Filings
2021-06-09 English
Quarterly Activity Report and Appendix 4C 7 pages 788.7KB
Interim / Quarterly Report
2021-04-26 English
LCT exits peptide projects 2 pages 448.6KB
Regulatory Filings
2021-03-28 English
Half Yearly Report and Accounts 21 pages 1.4MB
Interim / Quarterly Report
2021-02-24 English
Change in substantial holding 2 pages 64.2KB
Regulatory Filings
2021-02-16 English
Change in substantial holding 2 pages 1.2MB
Regulatory Filings
2021-02-14 English
Response to ASX Price Query 4 pages 544.7KB
Regulatory Filings
2021-02-11 English
Quarterly Activity Report and Appendix 4C 7 pages 750.7KB
Interim / Quarterly Report
2021-01-27 English
LCT CEO Dr Ken Taylor signals intention to retire 2 pages 439.8KB
Board/Management Information
2021-01-24 English
Appendix 3G 13 pages 796.4KB
Regulatory Filings
2021-01-18 English
Correction Notice - Appendix 3G 13 pages 783.9KB
Capital/Financing Update
2021-01-18 English
Change in substantial holding 2 pages 64.5KB
Regulatory Filings
2021-01-12 English